BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25068270)

  • 1. Autophagy-preferential degradation of MIR224 participates in hepatocellular carcinoma tumorigenesis.
    Lan SH; Wu SY; Zuchini R; Lin XZ; Su IJ; Tsai TF; Lin YJ; Wu CT; Liu HS
    Autophagy; 2014 Sep; 10(9):1687-9. PubMed ID: 25068270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224.
    Lan SH; Wu SY; Zuchini R; Lin XZ; Su IJ; Tsai TF; Lin YJ; Wu CT; Liu HS
    Hepatology; 2014 Feb; 59(2):505-17. PubMed ID: 23913306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis.
    Wu SY; Lan SH; Liu HS
    Autophagy; 2019 Apr; 15(4):729-730. PubMed ID: 30646811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
    Zhao Q; Li T; Qi J; Liu J; Qin C
    PLoS One; 2014; 9(10):e109782. PubMed ID: 25299640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
    Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
    Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
    Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
    Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
    Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system.
    Wu SY; Lan SH; Wu SR; Chiu YC; Lin XZ; Su IJ; Tsai TF; Yen CJ; Lu TH; Liang FW; Li CY; Su HJ; Su CL; Liu HS
    Hepatology; 2018 Jul; 68(1):141-154. PubMed ID: 29328502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
    Wu SY; Lan SH; Liu HS
    World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis.
    Chen W; Jiang J; Gong L; Shu Z; Xiang D; Zhang X; Bi K; Diao H
    J Exp Clin Cancer Res; 2021 Jan; 40(1):1. PubMed ID: 33390177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
    Zhang ZZ; Liu X; Wang DQ; Teng MK; Niu LW; Huang AL; Liang Z
    World J Gastroenterol; 2011 Jul; 17(28):3353-8. PubMed ID: 21876625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
    Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
    Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.